
---
nice.evidencecategory: 
---

### Evidence Statement CG66HES9
Conventional glucose control, mainly through diet was compared to more intense blood
glucose control with insulin or sulfonylureas in the UKPDS. Intensive treatment was costsaving
with the resource use according to the trial protocol. Using standard clinical resource
use, intensive treatment had an incremental cost-effectiveness ratio (ICER) of 1,166 per eventfree
year gained within the trial period (6% discount rate, 1997 cost year).98

